Prognostic model in advanced non-small cell lung cancer (NSCLC) patients treated with platinum-based chemotherapy

被引：0
|
作者：
Radosavljevic, D. Z. [1 ]
Gavrilovic, D. [1 ]
Golubicic, I. [1 ]
Jelic, S. [1 ]
机构：
[1] Inst Oncol & Radiol Serbia, Belgrade, Serbia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18046
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Mathematical model predicts response to chemotherapy in advanced non-resectable non-small cell lung cancer patients treated with platinum-based doublet
    Kozlowska, Emilia
    Suwinski, Rafal
    Giglok, Monika
    Swierniak, Andrzej
    Kimmel, Marek
    PLOS COMPUTATIONAL BIOLOGY, 2020, 16 (10)
  • [22] Phase II pharmacodynamic trial of erlotinib in advanced non-small cell lung cancer (NSCLC) patients previously treated with platinum-based chemotherapy: preliminary results
    Ross, HJ
    Blumenschein, GR
    Dowlati, A
    Aisner, J
    Rigas, JR
    Stanislaus, M
    Leopold, LH
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 645S - 645S
  • [23] Molecular profiles of predictive biomarkers for platinum-based chemotherapy in Non-Small Cell Lung Cancer (NSCLC)
    Seyedabadi, NiloofarTaleghani
    Shoushtari, Sara YousefZadeh
    Soofi, Asma
    Arabpour, Javad
    Shams, Zinat
    Akhavan, Homa
    Hosseini-Asl, Saied
    META GENE, 2022, 31
  • [24] PHARMACOGENETIC STUDY IN ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS TREATED WITH PLATINUM BASED CHEMOTHERAPY
    Sullivan, Ivana G.
    Salazar, Juliana
    Majem, Margarita
    Pallares, Cinta
    Del Rio, Elisabeth
    Berenguer, Antoni
    Paez, David
    Barnadas, Agusti
    Baiget, Montserrat
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S495 - S496
  • [25] Retrospective evaluation of thromboembolic events in patients with non-small cell lung cancer treated with platinum-based chemotherapy
    Mellema, Wouter W.
    van der Hoek, Dorien
    Postmus, Pieter E.
    Smit, Egbert F.
    LUNG CANCER, 2014, 86 (01) : 73 - 77
  • [26] Cyclooxygenase-2 expression is a prognostic biomarker for non-small cell lung cancer patients treated with adjuvant platinum-based chemotherapy
    Shimizu, Katsuhiko
    Yukawa, Takuro
    Okita, Riki
    Saisho, Shinsuke
    Maeda, Ai
    Nojima, Yuji
    Nakata, Masao
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2015, 13
  • [27] Clinical study of platinum-based chemotherapy in the treatment of elderly patients with advanced non-small cell lung cancer
    Zhang, Xiaotong
    Li, Longyun
    Lu, Bo
    CHEST, 2007, 132 (04) : 590S - 591S
  • [28] Cyclooxygenase-2 expression is a prognostic biomarker for non-small cell lung cancer patients treated with adjuvant platinum-based chemotherapy
    Katsuhiko Shimizu
    Takuro Yukawa
    Riki Okita
    Shinsuke Saisho
    Ai Maeda
    Yuji Nojima
    Masao Nakata
    World Journal of Surgical Oncology, 13
  • [29] CHEMOTHERAPY-INDUCED LEUKOPENIA AS A PROGNOSTIC FACTOR IN PATIENTS WITH METASTATIC NON-SMALL CELL LUNG CANCER TREATED WITH PLATINUM-BASED REGIMEN
    Huang, A.
    Han, B.
    Ma, M.
    Jin, B.
    Shen, J.
    Zhong, R.
    RESPIROLOGY, 2011, 16 : 131 - 131
  • [30] Platinum-based Doublet Chemotherapy plus Bevacizumab Without Bevacizumab Maintenance in Advanced Non-small Cell Lung Cancer (NSCLC)
    Noroxe, Dorte Schou
    Wallerek, Sandra
    Sorensen, Jens Benn
    ANTICANCER RESEARCH, 2013, 33 (08) : 3275 - 3278
12345